Tilaknagar Industries Ltd
Tilaknagar Industries Ltd. is primarily involved in manufacturing and sale of Indian Made Foreign Liquor (IMFL). [1]
- Market Cap ₹ 10,749 Cr.
- Current Price ₹ 435
- High / Low ₹ 550 / 335
- Stock P/E 42.6
- Book Value ₹ 121
- Dividend Yield 0.23 %
- ROCE 11.7 %
- ROE 12.9 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 61.0% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 45.0%
- Company's median sales growth is 26.2% of last 10 years
Cons
- Tax rate seems low
- Company has high debtors of 198 days.
- Promoter holding has decreased over last 3 years: -9.44%
- Working capital days have increased from 110 days to 157 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 551 | 372 | 381 | 308 | 489 | 649 | 549 | 783 | 1,164 | 1,394 | 1,434 | 2,346 | |
| 467 | 484 | 469 | 371 | 437 | 657 | 493 | 679 | 1,031 | 1,205 | 1,181 | 1,927 | |
| Operating Profit | 84 | -112 | -88 | -63 | 52 | -9 | 56 | 104 | 134 | 189 | 254 | 419 |
| OPM % | 15% | -30% | -23% | -20% | 11% | -1% | 10% | 13% | 11% | 14% | 18% | 18% |
| 2 | 0 | 2 | 32 | 2 | 474 | 12 | 10 | 103 | 13 | 27 | -207 | |
| Interest | 82 | 120 | 153 | 134 | 168 | 125 | 65 | 58 | 40 | 27 | 12 | 113 |
| Depreciation | 27 | 37 | 36 | 36 | 35 | 31 | 31 | 31 | 31 | 30 | 29 | 78 |
| Profit before tax | -23 | -268 | -275 | -201 | -149 | 309 | -29 | 25 | 166 | 146 | 239 | 21 |
| Tax % | 49% | -1% | -3% | -1% | 0% | 0% | -2% | -16% | -0% | 0% | -0% | 0% |
| -34 | -266 | -268 | -198 | -149 | 308 | -29 | 29 | 166 | 146 | 239 | 21 | |
| EPS in Rs | -2.77 | -21.32 | -21.49 | -15.87 | -11.90 | 24.61 | -2.30 | 1.83 | 8.95 | 7.56 | 12.37 | 0.83 |
| Dividend Payout % | -2% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 3% | 7% | 8% | 120% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 34% |
| 3 Years: | 26% |
| TTM: | 64% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 61% |
| 3 Years: | 55% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 64% |
| 3 Years: | 43% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 159 | 185 | 193 | 194 | 247 |
| Reserves | 383 | 112 | -113 | -310 | -457 | -149 | -178 | -38 | 300 | 472 | 709 | 2,755 |
| 787 | 845 | 1,028 | 989 | 1,072 | 535 | 663 | 584 | 254 | 120 | 43 | 2,300 | |
| 302 | 341 | 204 | 199 | 414 | 500 | 344 | 278 | 265 | 255 | 284 | 872 | |
| Total Liabilities | 1,596 | 1,423 | 1,244 | 1,003 | 1,154 | 1,011 | 955 | 982 | 1,005 | 1,040 | 1,230 | 6,174 |
| 555 | 530 | 494 | 541 | 506 | 481 | 450 | 422 | 403 | 380 | 354 | 3,757 | |
| CWIP | 15 | 15 | 15 | 15 | 15 | 0 | 0 | 0 | 0 | 0 | 3 | 16 |
| Investments | 46 | 42 | 42 | 48 | 48 | 48 | 48 | 64 | 44 | 33 | 61 | 63 |
| 980 | 835 | 693 | 399 | 585 | 482 | 457 | 497 | 557 | 627 | 811 | 2,337 | |
| Total Assets | 1,596 | 1,423 | 1,244 | 1,003 | 1,154 | 1,011 | 955 | 982 | 1,005 | 1,040 | 1,230 | 6,174 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 178 | 19 | 27 | 202 | 13 | 208 | 72 | 78 | 84 | 114 | 176 | -442 | |
| -84 | -9 | -1 | -25 | 0 | 0 | -0 | -43 | -19 | -11 | -75 | -3,573 | |
| -81 | -23 | -28 | -178 | -5 | -208 | -69 | -12 | -67 | -129 | -94 | 4,217 | |
| Net Cash Flow | 12 | -13 | -3 | -2 | 9 | 0 | 2 | 23 | -2 | -25 | 7 | 202 |
| Free Cash Flow | 93 | 7 | 24 | 178 | 12 | 207 | 71 | 74 | 75 | 108 | 171 | -3,931 |
| CFO/OP | 211% | -19% | -32% | -314% | 31% | -2,380% | 125% | 70% | 63% | 61% | 69% | -105% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 84 | 75 | 82 | 80 | 132 | 133 | 116 | 107 | 104 | 110 | 104 | 198 |
| Inventory Days | 134 | 145 | 108 | 227 | 273 | 116 | 198 | 142 | 152 | 113 | 191 | 117 |
| Days Payable | 166 | 218 | 185 | 467 | 544 | 272 | 369 | 321 | 165 | 134 | 170 | 98 |
| Cash Conversion Cycle | 52 | 2 | 6 | -159 | -139 | -23 | -54 | -71 | 91 | 89 | 126 | 217 |
| Working Capital Days | 76 | -84 | -491 | -1,067 | -700 | 43 | -73 | -17 | 18 | 79 | 96 | 157 |
| ROCE % | 5% | -12% | -11% | -7% | 2% | -3% | 6% | 13% | 15% | 22% | 28% | 12% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales Realization (NSR) per Case INR |
|
||||||||||
| Total Volumes Sold million cases |
|||||||||||
| Brandy Saliency (as % of total volumes) % |
|||||||||||
| Regional Sales Share - South India % |
|||||||||||
| Manufacturing Units Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 Jun - Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 we wish to inform you that the management shall be interacting with analyst/investors ....
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 Jun - Tilaknagar Industries to meet analysts and investors in Mumbai on June 12, 2026.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
8 Jun - Mr. Kishorekumar Mhatre ceased as Independent Director on June 08, 2026 after completing second five-year term.
-
Announcement under Regulation 30 (LODR)-Cessation
8 Jun - Mr. Kishorekumar Mhatre ceased as Independent Director on June 8, 2026 after completing two five-year terms.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 2 Jun
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
Jul 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Sep 2021TranscriptAI SummaryPPT
Company Overview[1]
Tilaknagar Industries Ltd. (TI) is an Indian alcoholic beverage company with a diverse portfolio of brands across various segments. The company is known for Mansion House Brandy, the largest-selling brandy in India and the second-largest globally.